ÂÜÀòÂÒÂ×

Jane Li currently serves as the Associate Director of Project Management at Switch Therapeutics, a position held since January 2023. Previously, Jane was the Sr. Development Project Manager at Rigel Pharmaceuticals Inc., where key responsibilities included managing cross-functional teams for the IRAK LR-MDS program and overseeing the Fostamatinib Phase 3 clinical trial, among other projects. Jane's experience also includes roles at Genentech, Applied StemCell, Optokey Inc., MD Anderson Cancer Center, and the Institute of Bioscience and Technology at Texas A&M, with a focus on project management, genomic editing, and research data. Jane earned a Master’s degree in Molecular Biology from the University of Houston.